// company-profile

KalVista Pharmaceuticals, Inc.

KALV
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings183Insiders23
// api This KalVista Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $0 across 50 transactions.

// 90-day insight

Over the last 90 days, KalVista Pharmaceuticals, Inc. insiders sold $0 across 50 transactions with no open-market purchases.

  • Most active insider: Palleiko Benjamin L with 18 transactions totaling $0.

Activity skews bearish — sales outpace buys.

Institutional Ownership

Top 13F-HR holders of KalVista Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$1.43B
QoQ change
+40.6%
Reporting period
2026-03-31
#1
Venrock Adviser, LLC
CIK 1615982
$130.3M
6.5M shares
#2
Frazier Life Sciences Management, L.P.
CIK 1892134
$99.9M
5.0M shares
#3
SUVRETTA CAPITAL MANAGEMENT, LLC
CIK 1569064
$96.0M
4.8M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Unkart Edward WKALV
Disposition
10,000
Jun 11, 2026Unkart Edward WKALV
Disposition
7,000
Jun 11, 2026Palleiko Benjamin LKALV
Disposition
92,560
Jun 11, 2026Unkart Edward WKALV
Disposition
6,000
Jun 11, 2026Palleiko Benjamin LKALV
Disposition
255,750

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.